3/2/20

The Rock Weekly

Why Apple and J&J’s heart study could be a big deal

While 30% of Americans used live video telemedicine in the past year, it has yet to fully shift from being a convenient consumer offering to a must-have. But as the emerging coronavirus puts pressure on an already overburdened healthcare system, digital tools could play a key role—with some limitations. On the Hill, lawmakers are pushing on reimbursement for and access to virtual consults during such emergencies.

Elsewhere, Apple and Johnson & Johnson teamed up with Rock Health portfolio company Evidation on an ambitious new study to see if the Apple Watch might help detect early signs of stroke (Best Buy’s involved, too). And health benefits navigation company Accolade filed its S-1 late Friday, revealing plans to raise up to $100M in an IPO.

Excited to build relationships with healthcare enterprise leaders? Rock Health’s partnerships team is growing—check out our open roles.

Headlines

A Look At What's In A Google Patient Data Sharing Contract
Even its best efforts to anonymize patient data aren’t 100% foolproof STAT+ | (Tweet)

HHS Releases Strategy To Reduce EHR Administrative Burden
The federal government identifies four areas to address Modern Healthcare | (Tweet)

If DNA Is Like Software, Can We Just Fix The Code?
A father’s foray into the world of hyper-personalized drugs MIT Technology Review | (Tweet)

Amazon, Microsoft Team Up With CTA On Healthcare AI Standards
+ FDA explores how to monitor AI in medical imaging FierceHealthcare | (Tweet)

Promising New Data For Akili's ADHD Treatment
But will the effects maintain over longer periods of time? MobiHealthNews | (Tweet)

What Big Tech Wants With Your Medical Data
They’re in it for the long haul Mashable | (Tweet)

Recent Funding

×